Global  

DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine

IndiaTimes Monday, 3 August 2020
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford University's Covid-19 vaccine candidate in the country, according to the Health Ministry.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again

COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again 01:38

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief...

You Might Like


💡 One News Page Knowledge: Other News Mentions

Drugs Controller General of India organization

COVID-19: DCGI approves CSIR's paper-based testing kit [Video]

COVID-19: DCGI approves CSIR's paper-based testing kit

Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR's paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, "Our Delhi CSIR lab's been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA. Mande further explained the functioning of the paper based test. "It's different as RTPCR detects RNA and amplifies it using a polymerase chain reaction that is costly. This paper-based test also detects RNA but by a CRISPR guided system. The paper lights up if there is any virus RNA to show a sample is positive, in 45 minutes," he added.

Credit: ANI    Duration: 02:43Published

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the..
DNA
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR [Video]

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.

Credit: ANI    Duration: 02:24Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Phase 3 human clinical trial of Oxford vaccine begins in Pune

The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at..
IndiaTimes
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published
Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning [Video]

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning

From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:18Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Farmers stage protest in Punjab, Karnataka over farm bills [Video]

Farmers stage protest in Punjab, Karnataka over farm bills

On September 25, a nation-wide protest is observed in wake of farm bills passed in Parliament. Farmers, under aegis of Bharatiya Kisan Union and Revolutionary Marxist Party of India (RMPI), blocked Amritsar-Delhi National Highway near Phillaur in Punjab. Similarly, members of Karnataka State Farmers' Association held protest near Bommanahalli on Karnataka-Tamil Nadu highway. Police personnel deployed in the area to ensure law and order is maintained and COVID safety norms are followed during protest.

Credit: ANI    Duration: 01:31Published

Watch: School climate strikes

We've live as school students strike for climate across the country. They're protesting against the funding of major gas projects, as part of the federal..
SBS

Covid-19 restrictions: 'Asian weddings have 400 guests - not 15'

British Asian weddings are traditionally lavish affairs that tend to have hundreds of guests.
BBC News

NSW arts scene gets a boost as state eases coronavirus restrictions for venues

NSW is easing coronavirus restrictions for certain entertainment venues after the state marked a third straight day without any locally acquired cases of..
SBS

Top N-scientist Sekhar Basu dies of Covid

Eminent nuclear scientist Sekhar Basu died of Covid-19 in a Kolkata hospital early Thursday, bringing the curtain down on a career that saw him championing major..
IndiaTimes

Ministry of Health and Family Welfare Cabinet ministry of Government of India

COVID-19 update: India crosses 58-lakh mark [Video]

COVID-19 update: India crosses 58-lakh mark

With continuous rise in COVID-19 cases, India crossed 58-lakh mark on September 25. A spike of 86,052 new cases and 1,141 deaths reported in last 24 hours. COVID-19 tally stands at 58,18,571 including 9,70,116 active cases, 47,56,165 cured/discharged/migrated and 92,290 deaths. According to Ministry of Health and Family Welfare (MoHFW), more than 13.80 lakh tests have been done in the last 24 hours.

Credit: ANI    Duration: 01:16Published

Official: COVID-19 kills 175 more in Iran

Tehran, Sept 24, IRNA - Iran's Health Ministry spokeswoman Sima Sadat Lari said on Thursday that some 175 more Iranians have died from coronavirus disease..
WorldNews
Country crosses 56-lakh mark with 83,347 new infections [Video]

Country crosses 56-lakh mark with 83,347 new infections

India's COVID-19 tally crossed 56-lakh mark on September 23 with a spike of 83,347 new infections. Total COVID-19 cases in the country stand at 56,46,011. Currently, there are 9,68,377 active cases. With 1,085 deaths in last 24 hours, the death toll rises to 90,020. Indian Council of Medical Research reported that 6,62,79,462 samples were tested up to September 22. Further, the Health Ministry informed that India's COVID-19 testing capacity surges to over 12 lakh daily tests.

Credit: ANI    Duration: 01:18Published

India has highest recoveries in world, says Union Health Ministry

India has reported the highest rate of Covid-19 recoveries in the world, which has crossed 80 per cent-mark, said Union Health Ministry here on Tuesday.
IndiaTimes

Oxford University Police Oxford University Police

Hancock on coronavirus vaccine trial pause [Video]

Hancock on coronavirus vaccine trial pause

Health Secretary Matt Hancock seeks to reassure the public as trials of the Oxford University Covid-19 vaccine have been put on hold owing to a reported side effect in a patient in the UK. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:37Published
FPL crowns new champion after controversy [Video]

FPL crowns new champion after controversy

The Fantasy Premier League has named a new winner for the 2019/20 season afterthe original was disqualified for a breach of the game’s terms and conditions.Josh Bull, a researcher in mathematical oncology at Oxford University, hasreplaced Bulgarian fantasy football manager Aleksandar Antonov two weeks afterthe end of the season.

Credit: PA - Press Association STUDIO    Duration: 01:22Published

Related videos from verified sources

UK will deliberately infect vaccine volunteers: report [Video]

UK will deliberately infect vaccine volunteers: report

Britain is planning to host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported on..

Credit: Reuters Studio     Duration: 01:22Published
Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials [Video]

Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials

The drugmaker made the announcement on Wednesday, joining the ranks of Pfizer and Moderna who have been in Phase 3 trials since July.

Credit: Cover Video STUDIO     Duration: 01:22Published
COVID-19 vaccine round-up: Johnson & Johnson begins Phase 3 trials in the United States [Video]

COVID-19 vaccine round-up: Johnson & Johnson begins Phase 3 trials in the United States

A large scale trial has kicked off today. Johnson & Johnson's coronavirus vaccine began its Phase 3 clinical trials. This is the fourth COVID-19 vaccine candidate to enter the final stage here in the..

Credit: WXYZ Detroit     Duration: 03:41Published

Related news from verified sources

Coronavirus | Number of recoveries goes past 25 lakh in India, says Health Ministry

Meanwhile, the cumulative number of COVID-19 tests conducted in the country has reached nearly 3.9 crore, it added.
Hindu Also reported by •IndiaTimesZee NewsMid-Day

Govt revives 2-year PG medical diploma courses

With an aim to address the shortage of specialists in district hospitals and in rural India, the health ministry has allowed two year postgraduate (PG) diploma...
IndiaTimes

India's COVID-19 recovery rate stands at 68.32 percent with 14.2 lakh recoveries

India's patients recovering from COVID-19 cross the 14.2 lakh mark, taking the recovery rate across the country to 68.32 per cent, said the Ministry of Health...
Mid-Day Also reported by •WorldNewsZee NewsIndiaTimes

Tweets about this